Deuterium-reinforced polyunsaturated fatty acids protect against atherosclerosis by lowering lipid peroxidation and hypercholesterolemia
- PMID:28655430
- DOI: 10.1016/j.atherosclerosis.2017.06.916
Deuterium-reinforced polyunsaturated fatty acids protect against atherosclerosis by lowering lipid peroxidation and hypercholesterolemia
Abstract
Background and aims: Oxidative modification of lipoproteins is a crucial step in atherosclerosis development. Isotopic-reinforced polyunsaturated fatty acids (D-PUFAs) are more resistant to reactive oxygen species-initiated chain reaction of lipid peroxidation than regular hydrogenated (H-)PUFAs. We aimed at investigating the effect of D-PUFA treatment on lipid peroxidation, hypercholesterolemia and atherosclerosis development.
Methods: Transgenic APOE*3-Leiden.CETP mice, a well-established model for human-like lipoprotein metabolism, were pre-treated with D-PUFAs or control H-PUFAs-containing diet (1.2%, w/w) for 4 weeks. Thereafter, mice were fed a Western-type diet (containing 0.15% cholesterol, w/w) for another 12 weeks, while continuing the D-/H-PUFA treatment.
Results: D-PUFA treatment markedly decreased hepatic and plasma F2-isoprostanes (approx. -80%) and prostaglandin F2α (approx. -40%) as compared to H-PUFA treatment. Moreover, D-PUFAs reduced body weight gain during the study (-54%) by decreasing body fat mass gain (-87%) without altering lean mass. D-PUFAs consistently reduced plasma total cholesterol levels (approx. -25%), as reflected in reduced plasma non-HDL-cholesterol (-28%). Additional analyses of hepatic cholesterol metabolism indicated that D-PUFAs reduced the hepatic cholesterol content (-21%). Sterol markers of intestinal cholesterol absorption and cholesterol breakdown were decreased. Markers of cholesterol synthesis were increased. Finally, D-PUFAs reduced atherosclerotic lesion area formation throughout the aortic root of the heart (-26%).
Conclusions: D-PUFAs reduce body weight gain, improve cholesterol handling and reduce atherosclerosis development by reducing lipid peroxidation and plasma cholesterol levels. D-PUFAs, therefore, represent a promising new strategy to broadly reduce rates of lipid peroxidation, and combat hypercholesterolemia and cardiovascular diseases.
Keywords: Atherosclerosis; Cholesterol metabolism; Hypercholesterolemia; Lipid peroxidation; Polyunsaturated fatty acids.
Copyright © 2017 Elsevier B.V. All rights reserved.
Comment in
- Combating atherosclerosis with heavy PUFAs: Deuteron not proton is the first.Tsikas D.Tsikas D.Atherosclerosis. 2017 Sep;264:79-82. doi: 10.1016/j.atherosclerosis.2017.07.018. Epub 2017 Jul 18.Atherosclerosis. 2017.PMID:28756876No abstract available.
Similar articles
- Deuterium-reinforced polyunsaturated fatty acids improve cognition in a mouse model of sporadic Alzheimer's disease.Elharram A, Czegledy NM, Golod M, Milne GL, Pollock E, Bennett BM, Shchepinov MS.Elharram A, et al.FEBS J. 2017 Dec;284(23):4083-4095. doi: 10.1111/febs.14291. Epub 2017 Oct 27.FEBS J. 2017.PMID:29024570Free PMC article.
- Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis.Liu C, Schönke M, Zhou E, Li Z, Kooijman S, Boon MR, Larsson M, Wallenius K, Dekker N, Barlind L, Peng XR, Wang Y, Rensen PCN.Liu C, et al.Cardiovasc Res. 2022 Jan 29;118(2):489-502. doi: 10.1093/cvr/cvab076.Cardiovasc Res. 2022.PMID:33693480Free PMC article.
- Pretreatment with n-6 PUFA protects against subsequent high fat diet induced atherosclerosis--potential role of oxidative stress-induced antioxidant defense.Penumetcha M, Song M, Merchant N, Parthasarathy S.Penumetcha M, et al.Atherosclerosis. 2012 Jan;220(1):53-8. doi: 10.1016/j.atherosclerosis.2011.10.001. Epub 2011 Oct 12.Atherosclerosis. 2012.PMID:22035574Free PMC article.
- The relation of lipid peroxidation processes with atherogenesis: a new theory on atherogenesis.Spiteller G.Spiteller G.Mol Nutr Food Res. 2005 Nov;49(11):999-1013. doi: 10.1002/mnfr.200500055.Mol Nutr Food Res. 2005.PMID:16270286Review.
- F2-isoprostanes as an indicator and risk factor for coronary heart disease.Davies SS, Roberts LJ 2nd.Davies SS, et al.Free Radic Biol Med. 2011 Mar 1;50(5):559-66. doi: 10.1016/j.freeradbiomed.2010.11.023. Epub 2010 Nov 30.Free Radic Biol Med. 2011.PMID:21126576Free PMC article.Review.
Cited by
- Deuterated docosahexaenoic acid protects against oxidative stress and geographic atrophy-like retinal degeneration in a mouse model with iron overload.Liu Y, Bell BA, Song Y, Zhang K, Anderson B, Axelsen PH, Bohannan W, Agbaga MP, Park HG, James G, Brenna JT, Schmidt K, Dunaief JL, Shchepinov MS.Liu Y, et al.Aging Cell. 2022 Apr;21(4):e13579. doi: 10.1111/acel.13579. Epub 2022 Mar 8.Aging Cell. 2022.PMID:35257475Free PMC article.
- Metformin intervention ameliorates AS in ApoE-/- mice through restoring gut dysbiosis and anti-inflammation.Yan N, Wang L, Li Y, Wang T, Yang L, Yan R, Wang H, Jia S.Yan N, et al.PLoS One. 2021 Jul 15;16(7):e0254321. doi: 10.1371/journal.pone.0254321. eCollection 2021.PLoS One. 2021.PMID:34264978Free PMC article.
- Lipidomics Reveals Dramatic Physiological Kinetic Isotope Effects during the Enzymatic Oxygenation of Polyunsaturated Fatty Acids Ex Vivo.Navratil AR, Shchepinov MS, Dennis EA.Navratil AR, et al.J Am Chem Soc. 2018 Jan 10;140(1):235-243. doi: 10.1021/jacs.7b09493. Epub 2017 Dec 19.J Am Chem Soc. 2018.PMID:29206462Free PMC article.
- Emerging Roles of 5-Lipoxygenase Phosphorylation in Inflammation and Cell Death.Sun QY, Zhou HH, Mao XY.Sun QY, et al.Oxid Med Cell Longev. 2019 Nov 29;2019:2749173. doi: 10.1155/2019/2749173. eCollection 2019.Oxid Med Cell Longev. 2019.PMID:31871543Free PMC article.Review.
- Deuterium-reinforced polyunsaturated fatty acids improve cognition in a mouse model of sporadic Alzheimer's disease.Elharram A, Czegledy NM, Golod M, Milne GL, Pollock E, Bennett BM, Shchepinov MS.Elharram A, et al.FEBS J. 2017 Dec;284(23):4083-4095. doi: 10.1111/febs.14291. Epub 2017 Oct 27.FEBS J. 2017.PMID:29024570Free PMC article.
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous